Check out our most popular compounded medications! Get Started
The Valsartan 2 mg/mL Oral Solution is a liquid formulation designed for oral administration, providing precise dosing and convenient delivery of medication. This solution is particularly beneficial for patients who require a specific dosage strength or have difficulty swallowing tablets or capsules.
Valsartan is primarily used to treat hypertension (high blood pressure) and heart failure, helping to improve cardiovascular health by relaxing blood vessels and reducing the workload on the heart. This formulation ensures that patients receive an accurate dose tailored to their individual needs, enhancing therapeutic outcomes and adherence to treatment regimens.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Valsartan 2 mg/mL Oral Solution is a customized liquid preparation designed to deliver precise dosing of valsartan, an angiotensin II receptor blocker (ARB) commonly used in the management of hypertension and heart failure. By inhibiting the action of angiotensin II, valsartan helps to relax and widen blood vessels, leading to lowered blood pressure and decreased strain on the heart.
This oral solution offers a significant advantage for patients who have difficulty swallowing tablets or require a dosage strength not readily available in commercial formulations. The liquid form ensures accurate dosing adjustments, which is crucial for achieving optimal therapeutic outcomes and reducing the risk of cardiovascular events such as stroke or myocardial infarction.
This flexibility allows healthcare providers to tailor treatment plans according to individual patient needs, ensuring better adherence and therapeutic success.
Patients prescribed this valsartan oral solution should take it exactly as directed by their healthcare provider. Regular monitoring of blood pressure is essential to assess the medication's effectiveness and make any necessary dosage adjustments. Patients should report any side effects such as dizziness, lightheadedness, or signs of hypotension to their healthcare provider promptly.
Healthcare providers should consider monitoring renal function and electrolyte levels periodically, as valsartan can affect kidney function and potassium levels, especially in patients with pre-existing renal conditions or those taking other medications that influence the renin-angiotensin system. It's important to review all concurrent medications to avoid potential drug interactions.
Common side effects may include headache, dizziness, fatigue, or elevated potassium levels. Patients are advised to avoid using potassium supplements or salt substitutes containing potassium unless instructed by their healthcare provider. Adherence to the prescribed regimen and open communication with healthcare professionals can significantly enhance the treatment's effectiveness and safety.
This compounded valsartan oral solution is prepared following stringent quality control standards to ensure its potency, stability, and safety. Prescribers can trust this formulation to meet the specific needs of their patients, especially when standard dosage forms are unsuitable, thus providing a personalized approach to managing conditions like hypertension and heart failure.
If you have any questions about Valsartan 2 mg/mL Oral Solution or need further information on how it can be integrated into treatment plans, please reach out to us.
Valsartan 2 mg/mL Oral Solution is an angiotensin II receptor blocker (ARB) used primarily for the treatment of hypertension, heart failure, and to improve survival following myocardial infarction. By blocking the action of angiotensin II, valsartan helps to relax blood vessels, thereby lowering blood pressure and reducing the workload on the heart. This liquid formulation is particularly beneficial for patients who require a specific dosage strength or have difficulty swallowing tablets.
When considering the use of Valsartan 2 mg/mL Oral Solution, it is important to be aware of potential drug interactions that may affect its efficacy or increase the risk of adverse effects. One significant interaction is with other antihypertensive agents, such as ACE inhibitors or other ARBs, which may lead to an additive effect, potentially causing hypotension. Patients should be monitored closely for signs of low blood pressure, such as dizziness or lightheadedness, especially when initiating or adjusting doses.
Concomitant use of valsartan with potassium-sparing diuretics, potassium supplements, or salt substitutes containing potassium can increase the risk of hyperkalemia, a condition characterized by elevated potassium levels in the blood. Symptoms of hyperkalemia may include muscle weakness, fatigue, and irregular heartbeats. Regular monitoring of serum potassium levels is recommended for patients at risk.
Nonsteroidal anti-inflammatory drugs (NSAIDs), including selective COX-2 inhibitors, may reduce the antihypertensive effect of valsartan. Additionally, in patients who are elderly, volume-depleted, or have compromised renal function, the concomitant use of NSAIDs and valsartan may lead to a deterioration of renal function, including possible acute renal failure. It is advisable to monitor renal function periodically in these patients.
Valsartan may interact with lithium, leading to increased serum lithium concentrations and potential lithium toxicity. Symptoms of lithium toxicity include nausea, vomiting, diarrhea, tremor, and confusion. If concurrent use is necessary, careful monitoring of serum lithium levels is recommended.
Rifampin, a potent inducer of hepatic enzymes, may decrease the plasma concentration of valsartan, potentially reducing its therapeutic effect. Patients should be monitored for adequate blood pressure control if these medications are used together.
Alcohol may enhance the hypotensive effect of valsartan, leading to an increased risk of dizziness or fainting. Patients should be advised to limit alcohol consumption while taking this medication.
As with any medication, it is crucial for both patients and prescribers to be aware of these potential interactions to ensure safe and appropriate use of Valsartan 2 mg/mL Oral Solution. If you have any questions or concerns regarding drug interactions or the use of this formulation, please reach out to us for further assistance.
The Valsartan 2 mg/mL Oral Solution is a liquid formulation designed to provide precise dosing and ease of administration, particularly beneficial for patients who require a specific dosage strength or have difficulty swallowing tablets or capsules. This formulation is especially useful for pediatric patients, elderly patients, or those with swallowing disorders, ensuring they receive the correct dose of medication in a form that is easy to ingest.
Valsartan is an angiotensin II receptor blocker (ARB) that works by inhibiting the action of angiotensin II, a potent vasoconstrictor. By blocking the binding of angiotensin II to its receptors, Valsartan effectively relaxes blood vessels, leading to a reduction in blood pressure.
In addition to its antihypertensive effects, Valsartan is also used in the management of heart failure and in patients who have experienced a heart attack. In heart failure, Valsartan helps to reduce the workload on the heart by decreasing systemic vascular resistance, thereby improving cardiac output and reducing symptoms such as shortness of breath and fatigue. For post-myocardial infarction patients, Valsartan aids in preventing further cardiac remodeling and deterioration of heart function, contributing to improved survival rates and quality of life.
The oral solution form of Valsartan allows for flexible dosing adjustments, which can be particularly advantageous in titrating the dose to achieve optimal therapeutic outcomes while minimizing side effects. This flexibility is crucial in managing conditions that require precise control of blood pressure or cardiac function, as it allows healthcare providers to tailor the treatment to the individual needs of each patient.
It ensures that patients receive the intended therapeutic benefits of Valsartan without the challenges associated with swallowing pills. For patients, this formulation provides a convenient and palatable way to manage their condition, supporting adherence to prescribed treatment regimens.
If you have any questions about the Valsartan 2 mg/mL Oral Solution or its use in treating specific disease states, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the information and support you need to make informed decisions about your healthcare.
Valsartan 2 mg/mL Oral Solution is primarily used for managing hypertension and heart failure, but it may have other potential applications that could be beneficial for both patients and prescribers. This liquid formulation is particularly advantageous for patients who have difficulty swallowing tablets or require precise dosing adjustments, such as pediatric patients or those with renal or hepatic impairments. In certain cases, Valsartan may be considered for off-label use in managing conditions like diabetic nephropathy, where it can help in reducing proteinuria and slowing the progression of kidney disease. Additionally, it may be used in patients with left ventricular dysfunction post-myocardial infarction to improve survival and reduce the risk of further cardiovascular events.
For patients with chronic kidney disease, Valsartan can be part of a therapeutic strategy to manage blood pressure and protect renal function, potentially delaying the need for dialysis. In some instances, it may also be used in combination with other antihypertensive agents to achieve better blood pressure control in resistant hypertension. The oral solution form allows for flexible dosing, which is crucial in titrating the medication to the optimal therapeutic dose while minimizing side effects. This flexibility is particularly important in populations such as the elderly or those with comorbid conditions, where polypharmacy is common, and drug interactions need to be carefully managed.
Prescribers should consider the patient's overall health status, existing comorbidities, and concurrent medications when contemplating the use of Valsartan for these additional purposes. The liquid formulation ensures that even those with swallowing difficulties or those requiring very specific dosing can benefit from the therapeutic effects of Valsartan. As always, any off-label use should be based on a thorough evaluation of the patient's condition and a careful consideration of the potential risks and benefits. If you have any questions or need further information about the use of Valsartan 2 mg/mL Oral Solution, please reach out to us at Bayview Pharmacy.
Valsartan 2 mg/mL Oral Solution is a liquid formulation containing the active ingredient Valsartan, dissolved in a suitable solvent for oral administration. It is designed to provide accurate dosing and convenient delivery of medication, particularly for patients who require a specific dosage strength or have difficulty swallowing tablets or capsules.
This oral solution is typically prescribed for patients who need a specific dosage strength of Valsartan or have difficulty swallowing solid dosage forms. It is often used in pediatric patients, elderly patients, or those with swallowing difficulties.
Valsartan 2 mg/mL Oral Solution should be taken exactly as prescribed by your healthcare provider. Use a proper measuring device to ensure accurate dosing. It is usually taken by mouth, with or without food, as directed by your doctor.
The oral solution form of Valsartan offers benefits such as precise dosing, ease of administration, and suitability for patients who have difficulty swallowing pills. It allows for flexible dosing adjustments and is often preferred for pediatric or geriatric patients.
As with any medication, Valsartan 2 mg/mL Oral Solution may cause side effects. Common side effects include dizziness, fatigue, and headache. If you experience any severe or persistent side effects, contact your healthcare provider immediately.
It is generally recommended to take Valsartan 2 mg/mL Oral Solution as directed by your healthcare provider. If you have difficulty taking it directly, consult your doctor or pharmacist before mixing it with food or drinks to ensure it does not affect the medication's efficacy.
Store Valsartan 2 mg/mL Oral Solution at room temperature, away from light and moisture. Keep it out of reach of children and pets. Do not store it in the bathroom, and ensure the bottle is tightly closed when not in use.
If you miss a dose of Valsartan 2 mg/mL Oral Solution, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up.
Do not stop taking Valsartan 2 mg/mL Oral Solution without consulting your healthcare provider, even if you feel better. Stopping the medication abruptly may worsen your condition or cause other health issues.
Valsartan is generally not recommended during pregnancy, especially in the second and third trimesters, due to potential harm to the fetus. If you are pregnant, planning to become pregnant, or breastfeeding, consult your healthcare provider before using this medication.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
